Crism Therapeutics Corporation Ord Npv (CRTX)

Sector:

Investment Firms

Index:

FTSE AIM All-Share

 9.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 18.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 32.68m
  • Volume: 52,308
  • Market Cap: £3.10m

Regulatory News

Clinical Trial Update 31-Mar-2025 07:00 RNS
Innovate UK Grant Award 27-Mar-2025 07:00 RNS
Appointment of Specialist Clinical CRO 20-Dec-2024 07:00 RNS
European Patent Grant 18-Dec-2024 07:00 RNS
Interim Results 19-Sep-2024 07:00 RNS
Notice of Interim Results & IMC Presentation 09-Sep-2024 07:00 RNS
Innovation Passport Award 02-Sep-2024 07:00 RNS
CRISM Signs Service Agreement Contract 30-Jul-2024 07:00 RNS
Response to Movement in Share Price 03-Jul-2024 16:18 RNS
Director Dealing 03-Jun-2024 15:25 RNS
Admission to Trading and First Day of Dealings 31-May-2024 07:00 RNS
Result of AGM and GM 29-May-2024 10:43 RNS
Schedule One - Amur Minerals Corporation 15-May-2024 08:00 RNS
Investor Presentation via Investor Meet Company 15-May-2024 07:00 RNS
Proposed Reverse Takeover 13-May-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CRTX Market Data

Currency UK Pounds
Share Price 9.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 18.00
52 Week Low 8.00
Volume 52,308
Shares Issued 32.68m
Market Cap £3.10m

CRTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Value Not Available
Income Not Available
Growth Not Available

CRTX Dividends

  Latest Previous
  Special Interim
Ex-Div 01-Jun-23 n/a
Paid 14-Jun-23 n/a
Amount 1.80p 0.000¢

Trades for 01-Apr-2025

Time Volume / Share Price
14:31 32 @ 8.60p
09:41 1,386 @ 8.60p
08:55 3,125 @ 8.60p
08:37 631 @ 8.00p
08:29 16,609 @ 8.60p

CRTX Key Personnel

CEO Andrew James Webb

Top of Page